MRI scans are strong diagnostics with high-definition images of what lies inside a body. Strong magnetic fields require precaution, as brought out by an instance where a young woman suffered very serious injuries due to an oversight in a metallic core within a silicone sex toy that she happened to have before the MRI scan. This makes a stark reminder about the potentially deadly consequences of missing metal objects when such procedures are being performed. In April 2023, a 23-year-old woman went into an MRI with a silicone plug containing a metal core that was not known.
She thought that the item is made entirely out of silicone according to the advertising. However, the strong magnetic field of the MRI machine interacted with the hidden metal, dragging the object through her body and causing excruciating pain. According to reports from the U.S. Food and Drug Administration (FDA), the scene was harrowing, with the woman screaming in agony and requiring immediate hospitalization. Despite pre-scan screenings, which are routine prior to a scan, the patient did not inform the facility that the object existed because he presumed it was purely non-metallic. This caused serious injuries that led to the patient's law suit against the manufacturer for deceitful misrepresentations of material content.
MRI machines employ magnets between 0.5 to 3 Tesla (T). This is thousands of times stronger than the Earth's magnetic field. The tremendous force causes ferromagnetic materials, like iron and nickel, to be magnetized quickly and become strongly attracted toward the magnet. Objects as small as hairpins or paper clips will accelerate at 40 miles per hour inside the magnetic field.
The force can lead to catastrophic injuries in items lodged within the body, such as metallic implants or foreign objects. Metallic cores within devices, like pacemakers or intrauterine devices, must be disclosed to radiologists to prevent such complications.
On these claims, Dr. Adam Taylor, a specialist in human anatomy, weighed his words in a international health website and added that the distance away and mass of this object would increase its velocity towards that of sound, "The acceleration would be phenomenal, but with a metallic core, it can't go anywhere near supersonic speeds. As for the size, the magnetic acceleration to the internal soft tissues would ensure that there could be severe intracranial trauma."
The injuries inflicted in this case likely involved damage to major blood vessels, nerves, or organs, highlighting the devastating impact of even minor oversight during an MRI scan.
This is not an isolated case. There are documented cases of metallic objects causing serious damage during MRI scans with a 65-year-old man with schizophrenia swallowed metal objects, including sockets and a hinge pin. The powerful magnetic field during an MRI scan caused the objects to rupture his stomach, resulting in serious injuries.
A toddler who ingested 11 small magnets perforated his bowel while undergoing a scan, making his case unique. In another deadly but extremely rare incident, there have been people who hide a firearm on themselves during MRI procedures. Magnetic attraction can trigger a discharge in a weapon and has led to some fatal injuries.
These cases emphasize the very strong need for adequate screening and patient education prior to an MRI.
Medical professionals have been trained to avoid risks. This is by properly screening a patient for metallic objects. In general, most pre-scan protocols include:
The case emphasizes the importance of product labeling by manufacturers, especially those products that are likely to unintentionally cause harm to health. The patient's assumption that her device was 100% silicone points to a larger problem in consumer markets with misinformation.
It also reminds the patients to report any possible dangers to the medical professionals, no matter how the objects look non-metallic. In sensitive cases, patients can request private discussions with healthcare providers to ensure safety without discomfort.
In the end, it is a joint effort from manufacturers, healthcare professionals, and patients that can prevent such tragedies. Manufacturers must ensure truthful marketing, while healthcare providers should educate patients about the dangers of metal objects in MRI settings. For patients, understanding the risks and actively participating in pre-scan disclosures can be lifesaving.
This young woman's experience is a sobering example of the unforeseen dangers posed by MRI machines when precautions are overlooked. It serves as a wake-up call to address gaps in patient awareness, medical protocols, and product transparency. By learning from this incident, the medical community and the public can work together to ensure MRI scans remain a safe and effective diagnostic tool.
Credit: National Weather Service
A dangerous heat dome is expected to engulf much of the eastern United States this week, exposing more than 220 million people to extreme heat as Americans prepare for the Fourth of July holiday weekend.
After scorching parts of Europe with record-breaking temperatures, the heatwave is now forecast to bring dangerously high daytime temperatures, oppressive humidity and unusually warm nights across much of the US, according to the National Weather Service (NWS).
"Dangerous, record-breaking heat will intensify across most of the central and eastern U.S. this week. Heat indices will likely exceed 100 degrees. Severe thunderstorms are forecast from parts of the central High Plains into the Upper Midwest, and across parts of the Northeast. Critical fire weather conditions will continue across portions of the Four Corners and Great Basin," the NWS said.
Also read: Europe Heatwave Shatters June Records: Paris Limits Alcohol Sales, F1 Declares Heat Hazard
The heat dome is expected to expand across the central and eastern United States, with the most intense heat peaking over the Midwest and Mississippi Valley by Thursday before spreading into the Ohio Valley and the East Coast through the holiday weekend.
Cities including New York City, Philadelphia, Baltimore and Washington, D.C. are forecast to see temperatures climb into the 100s°F (38°C and above).
Forecasters expect more than 100 daily temperature records and about 250 record-warm overnight temperatures through Saturday.
The heatwave will also extend into Canada, particularly southern Ontario and southern Quebec.
According to Environment Canada, millions of Canadians are under yellow and orange heat alerts, with advisories issued across Ontario, Quebec, Alberta, Saskatchewan and the Northwest Territories.
Temperatures in parts of Ontario and Quebec are expected to reach 34°C to 37°C on July 1 and July 2, coinciding with the Canada Day
holiday and the FIFA Club World Cup match in Toronto.
Extreme Heat Warnings have been issued for several major US cities, including:
Extreme Heat Watches cover much of the Northeast, where temperatures are expected to exceed 100°F (38°C) through Saturday.
Southern cities including Dallas, Little Rock and Memphis are also expected to face dangerous heat.
Meanwhile, the Four Corners region—covering parts of Utah, Colorado, New Mexico and Arizona—remains under critical fire weather conditions.
Read More: Heading to FIFA World Cup 2026? Here's How to Stay Safe From Measles, Heatstroke
Temperatures between 95°F and 105°F (35°C to 40.6°C), combined with high humidity, are expected to push the heat index to 100°F-115°F (38°C-46°C). Some areas could also break monthly or all-time temperature records.
Authorities have urged residents to limit outdoor activities, stay hydrated and seek air-conditioned spaces or cooling centres.
In New York City, Mayor Zohran Mamdani has activated the city's heat emergency plan, with hundreds of cooling centres opening across the city.
In Detroit, where temperatures could reach 100°F (38°C), officials have opened a dozen air-conditioned recreation centres for residents.
The extreme heat could also affect the FIFA Club World Cup, with some matches expected to exceed the heat-index threshold considered unsafe by the global players' union FIFPRO. Texas is expected to experience the hottest conditions, particularly affecting fans travelling to and from stadiums in Houston and Arlington.
In Canada, the heatwave has prompted officials to establish mobile drinking water stations in parks and extend public swimming pool hours to help residents cope with the extreme temperatures.
The US Centers for Disease Control and Prevention (CDC) says extreme heat can affect anyone. Warning signs include muscle cramps, dizziness, heavy sweating, headaches, nausea, weakness and shortness of breath.
To stay safe one must:
Credit: AI-generated image
Researchers at a Florida-based university claim that a tiny marine animal found in Antarctica can help scientists develop a new treatment for melanoma, one of the deadliest forms of skin cancer. These marine animals are ascidians, invertebrates known as sea squirts. Belonging to the group of tunicates, they mostly thrive in icy water.
Certain species of marine animals have proven to be useful in the treatment of various types of cancer. The latest ones are ascidians or sea squirts.
Researchers from the University of South Florida (USF) claim that sea squirts, small tube-shaped marine animals that produce protective chemicals, can help fight an aggressive form of skin cancer called melanoma.
Scientists say that these sea squirts have a bacterium that makes a toxic compound. In the early stages of the study, it was found that this compound is capable of killing melanoma cells without harming healthy cells.
Also read: Frequent Headaches: When To See A Doctor And Warning Signs To Watch For
One of the biggest challenges in cancer treatment is finding drugs that destroy cancer cells while leaving healthy cells unharmed. With this study, scientists say this compound produced by the bacteria inside Antarctic sea squirts can do exactly that, marking a significant milestone in cancer research.
In experiments conducted on mice, it was seen that the compound killed melanoma cells without causing serious harm to the rodents, making it a promising candidate for future drug development.
Even though it shows immense promise, the research is still in its early stages. Before the compound can be tested in people, scientists need to confirm that it is safe and effective in larger animal studies. Clinical trials on humans may still take a while.
Also read: How Reconstructive Plastic Surgery Transforms Lives After Trauma And Cancer
There is also a challenge of harvesting large numbers of sea squirts from Antarctica, as it would damage the fragile ecosystem. To avoid that, researchers are now working on creating the compound in the laboratory instead.
Despite encouraging results, it remains an experimental approach, and several years of research and clinical testing will be needed before it can become a trusted and proven therapy for melanoma.
Ecteinascidia turbinata, a colonial marine invertebrate, commonly called the golden sea squirt, has contributed to the development of Trabectedin, a chemotherapy drug, used to treat soft tissue sarcoma and ovarian cancer.
One of the significant cancer breakthroughs was due to sea sponges. They led to the development of Cytarabine, a chemotherapy medication that has been significant in the treatment of acute myeloid leukemia, acute lymphoblastic leukemia, and certain lymphomas for decades.
Sea cucumbers contain natural substances that can slow the growth and spread of cancer cells. Although research is still in its early stages, the results have been promising.
Researchers also found a powerful anti-cancer compound called dolastatin in sea hares. It inspired targeted cancer drugs that deliver treatment directly to cancer cells while reducing harm to healthy cells.
Credit: iStock
For the first time, starting July 1, people in the US will be able to access GLP-1 drugs for weight loss through a new pilot program offered by the federal health insurance program Medicare.
Until now, Medicare covered GLP-1 medications such as Ozempic only for certain conditions like diabetes, but not for weight loss.
The new 18-month Medicare GLP-1 Bridge Program, which will run till the end of 2027, aims to make these high-cost weight-loss medications more accessible to eligible beneficiaries.
According to a KFF analysis of 2023 Part D enrollment data, an estimated 3.8 million Medicare beneficiaries could qualify for the program.
More than 70 per cent of adults in the United States are considered to have obesity or screen as overweight. Studies have proven that GLP-1s are an effective tool in weight reduction, as well as improving other markers of good health, such as blood pressure, lipid profiles, and blood sugar levels.
Eligible beneficiaries will be able to access the following GLP-1 weight-loss medications:
The medications will be covered only when prescribed for weight management and when beneficiaries meet the program's medical eligibility criteria.
The program is available only to certain members of Medicare Part D prescription drug plans who want to lose excess weight and maintain weight loss.
Although the program operates outside standard Medicare Part D coverage, beneficiaries can participate only if they are enrolled in:
People enrolled in certain less common Medicare plans, including the Program of All-inclusive Care for the Elderly (PACE), may also qualify if they also have a stand-alone Part D plan, Washington Post reported.
According to the Centers for Medicare & Medicaid Services (CMS), most of Medicare's approximately 57 million Part D enrollees are in eligible plans.
However, coverage is not automatic. Providers and pharmacists will identify eligible patients, submit the required forms and obtain prior authorization before treatment can begin. Claims, prior authorization requests and pharmacy payments will be handled by Humana, while Part D plans will not be involved in the process.
Eligible beneficiaries will pay a $50 monthly copay for the covered medications.
However, because the program operates outside Medicare Part D coverage:
The pilot program is temporary and is scheduled to end in December 2027, unless it is extended.
"It's certainly good news for Medicare beneficiaries who have been essentially shut out of the market for GLP-1s for weight loss if they wanted to use insurance coverage. However, it is a temporary program. It is not a permanent change in Medicare coverage," said Juliette Cubanski, Vice President and Director of Medicare Policy at KFF.
If the program is not extended, beneficiaries who rely on the medications may have to pay higher out-of-pocket prices or discontinue treatment beginning in January 2028, which experts said could lead to weight regain based on current GLP-1 therapies, the Post reported.
© 2024 Bennett, Coleman & Company Limited